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1998). Furthermore, a few select imidazobenzodiazepines (which 
specifically target GABAA-Rs) are effective ethanol antagonists (e.g., 
Suzdak et al., 1986). However, despite overwhelming evidence that 
GABAA-Rs are primary targets of ethanol action, progress toward 
elucidation of the specific GABAA-R isoforms that mediate ethanol 
and ethanol antagonist action has been challenging and plagued by 
controversy (Lovinger and Homanics, 2007). Definitive elucidation 
of the targets of ethanol and ethanol antagonists has the potential to 
dramatically impact the search for effective treatments for alcohol 
abuse and alcoholism.
The development of specific ethanol antagonists has been the 
focus of much research since the discovery of Ro15-4513 – an imi-
dazobenzodiazepine drug synthesized by Hoffmann-La Roche & 
Co. Ro15-4513 acts as an ethanol antagonist both in biochemical 
assays (Kolata, 1986; Suzdak et al., 1986) and behavioral studies 
(Lister and Nutt, 1988; Suzdak et al., 1988; Samson et al., 1989; 
Becker and Hale, 1991). Behaviorally, Ro15-4513 antagonizes the 
IntroductIon
The  molecular  mechanisms  by  which  alcohol  (ethanol)  exerts 
its effects on the brain largely remain an enigma. Understanding 
the mechanisms of action of this widely used drug is essential for 
the rational design of therapeutic interventions to combat alcohol 
use disorders. Although ethanol is consumed for its many pleasur-
able effects, the adverse effects of ethanol consumption are stag-
gering. Alcohol use disorders in the United States alone annually 
are responsible for 105,000 deaths (McGinnis and Foege, 1999) 
and cost society at least $185 billion. The personal costs to those 
affected are incalculable.
γ-Aminobutyric acid (GABA) type A receptors (GABAA-Rs) have 
long been implicated as key molecular targets of ethanol because 
drugs that are known to act via GABAA-Rs (i.e., benzodiazepines, 
barbiturates) produce behavioral effects that are similar to ethanol 
intoxication (e.g., Hu et al., 1987). Tolerance to these GABAergic 
agents also produces cross tolerance to ethanol (e.g., Khanna et al., 
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Alcohol (ethanol) is widely consumed for its desirable effects but unfortunately has strong 
addiction potential. Some imidazobenzodiazepines such as Ro15-4513 are able to antagonize 
many ethanol-induced behaviors. Controversial biochemical and pharmacological evidence 
suggest that the effects of these ethanol antagonists and ethanol are mediated specifically 
via overlapping binding sites on α4/δ-containing GABAA-Rs. To investigate the requirement 
of α4-containing GABAA-Rs in the mechanism of action of Ro15-4513 on behavior, wildtype 
(WT) and α4 knockout (KO) mice were compared for antagonism of ethanol-induced motor 
incoordination and hypnosis. Motor effects of ethanol were tested in two different fixed speed 
rotarod assays. In the first experiment, mice were injected with 2.0 g/kg ethanol followed 
5 min later by 10 mg/kg Ro15-4513 (or vehicle) and tested on a rotarod at 8 rpm. In the second 
experiment, mice received a single injection of 1.5 g/kg ethanol ± 3 mg/kg Ro15-4513 and 
were tested on a rotarod at 12 rpm. In both experiments, the robust Ro15-4513 antagonism 
of ethanol-induced motor ataxia that was observed in WT mice was absent in KO mice. A loss 
of righting reflex (LORR) assay was used to test Ro15-4513 (20 mg/kg) antagonism of ethanol 
(3.5 g/kg)-induced hypnosis. An effect of sex was observed on the LORR assay, so males and 
females were analyzed separately. In male mice, Ro15-4513 markedly reduced ethanol-induced 
LORR in WT controls, but α4 KO mice were insensitive to this effect of Ro15-4513. In contrast, 
female KO mice did not differ from WT controls in the antagonistic effects of Ro15-4513 on 
ethanol-induced LORR. We conclude that Ro15-4513 requires α4-containing receptors for 
antagonism of ethanol-induced LORR (in males) and motor ataxia.
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sant effects of ethanol, but not the hypothermic or lethal effects 
(For reviews, see Wallner et al., 2006a; Wallner and Olsen, 2008). 
Ro15-4513 has minimal intrinsic effects at doses that antagonize 
ethanol action (Bonetti et al., 1988; Glowa et al., 1988). In spite of 
Ro15-4513’s clear behavioral effects, the molecular mechanism of 
action of Ro15-4513 has not been conclusively established. With the 
recent discovery of GABAA-Rs (α4/6β2/3δ) that are highly sensi-
tive to sobriety impairing concentrations of ethanol (Sundstrom-
Poromaa et al., 2002; Wallner et al., 2003), interest in the molecular 
mechanism of action of Ro15-4513 has been revived.
GABAA-R isoforms composed of α4/6β2/3δ are mired in con-
troversy regarding their role in the mechanisms of action of both 
ethanol and the imidazobenzodiazepine Ro15-4513. While numer-
ous studies have presented persuasive evidence that these receptor 
subtypes are very sensitive to potentiation by low concentrations 
of ethanol (Sundstrom-Poromaa et al., 2002; Wallner et al., 2003; 
Wei et al., 2004; Hanchar et al., 2005; Fleming et al., 2007; Mody 
et al., 2007; Olsen et al., 2007; Santhakumar et al., 2007), others 
have failed to observe this pharmacology (Borghese et al., 2006; 
Storustovu and Ebert, 2006; Yamashita et al., 2006; Casagrande 
et al., 2007). Similarly, it has been difficult to reach a consensus on 
the pharmacology of Ro15-4513 at these receptors. Until recently, it 
was generally accepted that the γ2 subunit was required for benzo-
diazepine binding. Remarkably, α4/α6βδ containing receptors were 
recently shown to bind Ro15-4513 with low nanomolar affinity 
(Hanchar et al., 2006) and Ro15-4513 was able to reverse the effects 
of ethanol on these receptors (Wallner et al., 2006b). Competitive 
binding studies revealed that flumazenil and β-carboline derivatives 
also displaced bound Ro15-4513 from α4δ-containing receptors 
(Hanchar et al., 2006). Furthermore, Ro15-4513 binding was also 
dose dependently inhibited by ethanol (Hanchar et al., 2006). The 
conclusion of these studies was that a common binding pocket 
exists on α4/α6βδ GABAA-Rs that mediates ethanol action and 
Ro15-4513 antagonism of ethanol action (Hanchar et al., 2006; 
Wallner et al., 2006b). However, despite the convincing nature of 
these studies, results of other studies have failed to support such a 
mechanism. Korpi et al. (2007) failed to detect high affinity Ro15-
4513 binding to recombinant α4/α6δ containing receptors or to 
cerebellar sections containing native α6δ receptors. Mehta et al. 
(2007) failed to observe ethanol inhibition of Ro15-4513 bind-
ing to δ-containing GABAA-Rs from rat brain. Thus, the evidence 
that ethanol and Ro15-4513 compete for a binding site on α4/6δ 
GABAA-Rs is equivocal at present.
In  summary,  it  is  firmly  established  that  imidazobenzodi-
azepines such as Ro15-4513 antagonize some of the behavioral 
effects of ethanol, but the mechanism of action of these drugs is 
highly controversial. Results of several electrophysiologic and phar-
macologic binding studies suggest that ethanol and these ethanol 
antagonists compete for a common binding pocket on α4/α6δ 
containing GABAA-Rs (Hanchar et al., 2006; Wallner et al., 2006b). 
However, to date no studies investigating involvement of α4 recep-
tors in Ro15-4513 antagonsim of ethanol action have examined 
this on the behavioral level. Therefore, to test the hypothesis that 
α4-containing receptors are required for Ro15-4513 antagonism 
of ethanol-induced behaviors, α4 wildtype (WT), and knockout 
(KO) mice (Chandra et al., 2006) were compared on ethanol-
induced behavioral assays that are known to be antagonized by 
Ro15-4513. We previously demonstrated that moderate to high 
dose ethanol-induced behavioral responses were normal in the KO 
mice (Chandra et al., 2008) and at the cellular level, tonic current 
potentiation by Ro15-4513 was reduced in dentate gyrus granule 
neurons of α4 KO mice (Liang et al., 2008).
MaterIals and Methods
subjects
Homozygous α4 KO and WT littermate mice of the F3–4 generations 
were derived from mixed background (C57BL/6J and Strain 129S1/
X1) heterozygous parents as described (Chandra et al., 2006). Mice 
were group housed, kept on an alternating 12 h light–dark cycle and 
allowed access to food and water ad libitum. Mice were genotyped 
by Southern Blot analysis of tail DNA (Chandra et al., 2006). All ani-
mals were between 8 and 16 weeks of age at the time of behavioral 
testing. All experiments were approved by the Institutional Animal 
Care and Use Committee at the University of Pittsburgh and were 
conducted in compliance with the Guide for the Care and Use of 
Laboratory Animals. Mice were tested for antagonism of ethanol 
induced behaviors by the imidazobenzodiazepine Ro15-4513 as 
described below. Control experiments with Ro15-4513 alone were 
not conducted.
ro15-4513 antagonIsM of ethanol-Induced Motor ataxIa
Two separate experiments were performed using fixed speed rotarod 
assays. Ro15-4513 was a generous gift from Roche Biomedical 
Laboratories Inc. (Burlington, NC, USA). Ethanol used in all experi-
ments was 200 proof absolute ethanol, ACS/USP grade obtained 
from Pharmco (Brookfield, CT, USA).
For the first rotarod experiment, mice were injected with ethanol 
(2 g/kg) 5 min prior to injection with Ro15-4513 (10 mg/kg) or 
vehicle (0.3% Tween-80 in saline). Ro15-4513 was freshly prepared 
in 0.3% Tween-80 in saline at 1 mg/ml on the morning of the exper-
iment in BD Falcon round bottomed tubes. A uniform suspension 
was achieved by sonicating (Fisher Scientific Sonic Dismembrator 
Model 100) on ice. Test animals were transferred in their cages to 
a behavioral testing room ∼24 h before the experiment. Mice were 
weighed and subjected to training trials on a fixed speed rotarod 
(Ugo Basile 7650, Varese, Italy) at 8 rpm. Mice were given at least 
four training trials to achieve a performance of 100 s on the rotarod. 
Training trials were administered 15 min apart. No differences were 
observed between genotypes in training to baseline performance on 
these or previously published (Chandra et al., 2010) experiments. 
Following training, mice were housed overnight in the testing room. 
On the test day, mice were re-tested at least twice on the rotarod 
to ensure compliance with criteria. Mice that did not achieve the 
criterion of 100 s on two consecutive trials were excluded from 
the experiment (n = 1 WT and 1 KO). Following this, ethanol and 
Ro15-4513 injections were administered in a volume of 0.01 ml/g 
body weight. Mice were tested for rotarod performance at 15, 30, 
45, and 60 min following injection.
The second rotarod experiment was similar to the first experi-
ment with the following exceptions. Ro15-4513 (3 mg/kg) and 
ethanol (1.5 g/kg) were administered as a single i.p. injection 
in a volume of 0.01 ml/g body weight. Control treated animals 
received ethanol alone. Ro15-4513 was prepared directly in etha-
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treatment, genotype, or interaction. These data were also analyzed 
using a more conservative statistical approach by comparing the 
AUCs. An overall ANOVA conducted on the AUCs indicated that 
the effect of genotype, treatment, and the interaction of genotype 
with treatment were not significant.
A second test of Ro15-4513 antagonism of ethanol-induced 
motor ataxia was conducted using a slightly different experi-
mental  protocol.  The  ability  of  Ro15-4513  to  antagonize 
  ethanol-induced  motor  ataxia  was  tested  on  a  fixed  speed 
rotarod (12 rpm) assay following a single injection of either 
1.5  g/kg  ethanol  alone  or  the  same  dose  of  ethanol  plus   
3 mg/kg Ro15-4513. This was done to increase the bioavailability 
of Ro15-4513. Because a lower dose of ethanol was used, the speed 
of the rotarod had to be increased to make the task sufficiently 
difficult. Rotarod performance is shown in Figure 1C. Two-way 
ANOVA on the 15-min time point revealed a significant effect of 
treatment (F1,33 = 23, p < 0.0001), treatment by genotype inter-
action (F1,33 = 13, p ≤ 0.001), but no effect of genotype. Post hoc 
analysis of the 15-min time point within each genotype revealed 
that Ro15-4513 antagonized the effects of ethanol in WT mice 
(p < 0.0001) but not in KO mice. Two-way ANOVA on the 30-min 
time point revealed a significant effect of treatment (F1,33 = 5, 
p < 0.05), treatment by genotype interaction (F1,33 = 4, p ≤ 0.05), 
but no effect of genotype. Post hoc analysis of the 30-min time 
point within each genotype revealed that Ro15-4513 antagonized 
the effects of ethanol in WT mice (p < 0.01) but not in KO mice. 
Comparison of the performance on the rotarod at the 45- and 
60-min time points by two-way ANOVA did not reveal an effect 
of treatment, genotype, or interaction. To compare groups using 
a more conservative statistical approach, area under the response 
curves were calculated (Figure 1D). ANOVA conducted on AUC’s 
revealed a main effect of treatment (F1,33 = 14, p < 0.001) and an 
interaction of treatment with genotype (F1,33 = 8, p < 0.01). The 
effect of genotype alone was not significant. Fisher’s post hoc tests 
revealed that WT and KO mice did not differ in their response 
to ethanol alone. Ro15-4513 reduced the amount of ethanol-
induced motor ataxia in WT (p < 0.0001) but not in KO mice. 
Thus, Ro15-4513 robustly antagonized ethanol-induced motor 
ataxia in WT mice, but Ro15-4513 was without effect in GABAA-R 
α4 subunit KO mice.
Male α4 Ko MIce are resIstant to ro15-4513 antagonIsM of 
ethanol-Induced lorr
Antagonism  of  ethanol  (3.5  g/kg)-induced  LORR  by  Ro15-
4513 (20 mg/kg) yielded an overall effect of gender (F1,74 = 16, 
p < 0.0001). Hence, males and females were analyzed separately. 
In males (Figure 2A), a two-way ANOVA revealed a main effect 
of treatment (F1,36 = 4, p ≤ 0.05), an interaction of genotype with 
treatment (F1,36 = 9, p < 0.01), but not a main effect of genotype. 
Post hoc analysis revealed no differences in duration of LORR 
between WT and KO mice that received ethanol alone. Ro15-
4513 reduced the duration of ethanol-induced LORR in WT mice 
(p < 0.0005) compared to ethanol alone. In contrast, Ro15-4513 
had no effect the duration of ethanol-induced LORR in KO mice. 
Thus, male α4 KO mice are resistant to Ro15-4513 antagonism of 
  ethanol-induced LORR.
nol (1.57 mg/ml) by heating in a water bath with temperature not 
exceeding 65°C and intermittent vortexing. This stock solution 
was prepared on the day of the experiment in BD Falcon round 
bottomed tubes and was diluted with saline to a final concentra-
tion of 0.3 mg/ml Ro15-4513 in 15% ethanol immediately prior 
to injection. This method of preparation was adopted to enhance 
the bioavailability of Ro15-4513 (personal communication with 
Dr. Martin Wallner, UCLA). The chemical identity of Ro15-4513 
was not confirmed following the solubilization procedure. To 
make the task sufficiently difficult for these doses, the mice were 
tested on a fixed speed rotarod at 12 rpm. All training and testing 
procedures were conducted similar to the first experiment. One 
WT animal did not perform to criteria on the test day and was 
therefore excluded.
antagonIsM of ethanol-Induced lorr by ro15-4513
Mice were injected i.p. with Ro15-4513 (20 mg/kg; 0.01 ml/g BW) or 
vehicle 15 min prior to i.p. injection with ethanol (3.5 g/kg; 0.02 ml/g 
BW). Ro15-4513 was prepared in 0.3% Tween-80 in saline as described 
in the first rotarod experiment. Upon losing their righting reflex, mice 
were placed in a supine position on V-shaped troughs. Mice were con-
sidered to have regained their righting reflex if they were successful in 
righting themselves three consecutive times within 30 s. A heat lamp 
was used during the course of the experiment to ensure normothermia.
data analysIs and statIstIcs
 All results are presented as mean ± SEM. For all experiments, 
data were analyzed for an effect of sex. Except where noted below, 
no effect of sex was observed and males and females were com-
bined for further analysis. For the rotarod experiments, two dif-
ferent statistical analyses were conducted. First, performance on 
the rotarod at each timepoint was compared by two-way ANOVA 
followed by Fisher’s post hoc test where appropriate. Second, area 
under curves (AUC) were calculated for each genotype-treatment 
combination. AUCs were calculated as the area between baseline 
performance (100 s) and the performance curve of each genotype 
over the 60-min period. AUCs were compared by two-way ANOVA 
followed by Fisher’s post hoc test where appropriate. The loss of 
righting reflex (LORR) experiments were analyzed by two-way 
ANOVA and Fisher’s post hoc tests.
results
α4 Ko MIce are resIstant to ro15-4513 antagonIsM of ethanol-
Induced Motor ataxIa
The ability of Ro15-4513 to antagonize ethanol-induced motor 
ataxia was initially tested on a fixed speed rotarod (8 rpm) fol-
lowing injection with 2 g/kg ethanol 5 min before injection with 
10 mg/kg Ro15-4513 or vehicle. Rotarod performance and AUCs 
are shown in Figures 1A,B, respectively. Comparison of perform-
ance on the rotarod at the 15-min time point by two-way ANOVA 
revealed an effect of treatment (F1,41 = 5, p < 0.05), an interaction 
of treatment with genotype (F1,41 = 6, p < 0.05), and a trend for 
an effect of genotype alone (F1,41 = 3, p = 0.077). Post hoc analysis 
comparing the effect of Ro15-4513 vs vehicle within each genotype 
at the 15-min time point revealed that Ro15-4513 antagonized 
the effect of ethanol in WT mice (p = 0.01), but not in KO mice. 
Comparison of the performance on the rotarod at the 30-, 45-, and 
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the behavioral level. The results of the present study revealed that 
α4-containing receptors are required for the ethanol antagonis-
tic effects of Ro15-4513 on behavior. In addition, consistent with 
previous observations (Chandra et al., 2008), we confirmed that 
the behavioral effects of ethanol alone were comparable between 
WT and α4 KO mice.
We first tested the effects of Ro15-4513 on ethanol-induced 
motor ataxia. Previous studies established that ethanol-induced 
motor  incoordination  is  robustly  antagonized  by  Ro15-4513 
(Hoffman et al., 1987; Stinchcomb et al., 1989; Dar, 1995). We 
previously reported that tonic current potentiation by Ro15-4513 
is ablated in α4 KO hippocampal dentate granule neurons (Liang 
et  al.,  2008).  Administration  of  Ro15-4513  reduced  ethanol-
induced motor ataxia and improved performance in WT mice but 
not in KO mice. Thus, α4 KO mice were completely insensitive to 
Analysis of female mice (Figure 2B) revealed a main effect of 
treatment (F1,37 = 18, p < 0.001) but no effect of genotype or inter-
action of genotype with treatment. Note, one female KO mouse 
treated with Ro15-4513 + ethanol whose duration of LORR was 
greater than 2 SD from the group mean was excluded from this 
analysis. Thus, in female mice, Ro15-4513 reduced the duration of 
ethanol-induced LORR but this was not influenced by genotype.
dIscussIon
The primary goal of this study was to test the hypothesis that 
α4-containing GABAA-Rs are required in vivo for the mechanism 
by which the imidazobenzodiazepine Ro15-4513 antagonizes the 
behavioral signs of ethanol intoxication. Previous publications pro-
vided pharmacologic and electrophysiologic evidence for (Hanchar 
et al., 2006; Wallner et al., 2006b) and against (Cook et al., 2005; 
Korpi et al., 2007; Mehta et al., 2007) this hypothesis, but none of 
FiGuRe 1 | Ro15-4513 antagonism of ethanol-induced motor ataxia. (A) 
Performance of WT and GABAA-Rα4 subunit KO mice on fixed speed (8 rpm) 
rotarod following pretreatment with 2 g/kg ethanol 5 min prior to treatment 
with 10 mg/kg Ro15-4513 or vehicle.*p ≤ 0.01 – WT ethanol/vehicle vs WT 
ethanol/Ro15-4513. (B) AUCs of response curves in (A). Effect of genotype, 
treatment, and the interaction were not significant. (C) Performance on fixed 
speed (12 rpm) rotarod following treatment with 1.5 g/kg ethanol ±3 mg/kg 
Ro15-4513. *p < 0.005, **p < 0.0001 – WT ethanol vs WT ethanol + Ro15-
4513. (D) AUCs of response curves in (C). WT and KO mice did not differ 
following injection of ethanol alone. Ro15-4513 antagonized ethanol- 
induced motor ataxia in WT, but not in KO mice. All values are expressed  
as mean ± SEM.
Iyer et al.  α4 GABAA-Rs and Ro15-4513 action
Frontiers in Pharmacology  | Neuropharmacology    April 2011  | Volume 2  | Article 18  |  4effect of Ro15-4513. Thus, we conclude that in male mice, Ro15-
4513 functions through α4-containing GABAA-Rs to antagonize 
ethanol-induced hypnosis.
GABAA-Rs containing α4 do not appear to be universal targets 
for all ethanol-induced behaviors that are sensitive to antagonism 
by Ro15-4513. It has been reported that Ro15-4513 antagonism 
of operant responding for ethanol is mediated in part by α5 con-
taining GABAA-Rs (Stephens et al., 2005). It would be of obvious 
interest to test α4 KO mice for this effect of Ro15-4513 to determine 
if α4 also contributes to this behavioral effect. However, we have 
not done so to date.
If ethanol and Ro15-4513 compete for a common binding site 
on α4/δ receptors that is responsible for the behavioral effects 
of these drugs as proposed (Hanchar et al., 2006; Wallner et al., 
2006b), why are α4 KO mice resistant to Ro15-4513 but not etha-
nol alone (Chandra et al., 2008)? Ethanol most certainly exerts 
its behavioral effects via multiple targets in addition to α4/δ 
GABAA-Rs, including many non-GABAA-R targets. Therefore, it 
is conceivable that the targets of ethanol that remain in the KO 
masked the absence of α4. Alternatively, global KO of α4may 
have resulted in developmental alterations that compensated for 
the ethanol response at α4 GABAA-Rs. In contrast, imidazoben-
zodiazepines like Ro15-4513 exert their effects exclusively via 
GABAA-Rs. This potentially reduces the possibility of masking 
or compensating for the absence of α4 GABAA-Rs. In direct 
support of this suggestion, we have observed that in dentate 
gyrus following KO of α4 and ablation of ethanol potentiation 
of extrasynaptic tonic currents, synaptic responses to ethanol 
are markedly increased (Liang et al., 2008). In contrast, fol-
lowing KO of α4 and ablation of Ro15-4513 potentiation of 
extrasynaptic tonic currents, synaptic responses to Ro15-4513 
are unaltered (Liang et al., 2008).While it is unlikely that the 
hippocampus is the primary brain region underlying ethanol-
induced motor impairment, it is likely that the compensation 
observed in hippocampus also takes place in other brain regions 
(Liang et al., 2008).
While the results in this report demonstrate a clear require-
ment for α4-containing GABAA-R for Ro15-4513 antagonism 
of ethanol-induced motor incoordination and LORR, this study 
alone does not reveal the α4 subunit partners that are responsible, 
i.e., we cannot distinguish between α4β×δ and α4β×γ2 combina-
tions. We previously reported that tonic current potentiation by 
Ro15-4513 was ablated in α4 KO hippocampal dentate granule 
neurons (Liang et al., 2008). Presumably, this Ro15-4513 sensi-
tive tonic current that was ablated was normally composed of 
α4βγ2-containing GABAA-Rs since they are markedly potentiated 
by Ro15-4513 whereas α4δ-containing receptors are not (Wallner 
et al., 2006b). Even though α4δ receptors are not potentiated 
by Ro15-4513, they still bind this compound with high affinity 
(Hanchar et al., 2006) and it has been proposed that this binding 
to α4δ receptors antagonizes the effects of ethanol (Hanchar et al., 
2006; Wallner et al., 2006b). However, our previously reported 
results that Ro15-4513 antagonism of ethanol-induced LORR 
was normal in δ subunit KO mice (Mihalek et al., 2001) argue 
against this. Thus, for ethanol-induced LORR, it appears that δ is 
not required for antagonism by Ro15-4513. This conclusion is in 
agreement with the recent report demonstrating that Ro15-4513 
Ro15-4513 reversal of ethanol-induced motor incoordination. In 
contrast, WT mice showed varying degrees of reversal that may 
have been dependent upon dose and/or method of preparation/
administration of the drug. These results are most consistent with 
the hypothesis that Ro15-4513 functions through α4-containing 
GABAA-Rs to antagonize ethanol-induced motor ataxia.
We also tested Ro15-4513 reversal of ethanol-induced hypnosis 
using the LORR assay. Previous studies have demonstrated that 
Ro15-4513 was able to partially reverse this high dose ethanol 
effect (Harris et al., 1995; Homanics et al., 1997; Mihalek et al., 
2001). The duration of ethanol-induced LORR was reduced by 
∼52% in WT males by Ro15-4513. In stark contrast, Ro15-4513 had 
no effect on the duration of ethanol-induced LORR in KO males. 
This is also consistent with the lack of effect of Ro15-4513 on tonic 
current potentiation in α4 KO neurons compared to WT (Liang 
et al., 2008). Results with female mice revealed that Ro15-4513 
antagonized ethanol-induced LORR, but this was not influenced 
by genotype. Thus, males and females respond differently to this 
FiGuRe 2 | Antagonism of ethanol (3.5 g/kg)-induced LORR by Ro15-4513 
(20 mg/kg). (A) In male mice, Ro15-4513 antagonized the duration of 
ethanol-induced LORR in WT, but not in KO. (B) In female mice, Ro15-4513 
antagonized ethanol-induced LORR (p < 0.0001) irrespective of genotype. All 
values are expressed as mean ± SEM.
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